NUVATION BIO INC's ticker is NUVB and the CUSIP is 67080N101. A total of 126 filers reported holding NUVATION BIO INC in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,316,173 | -23.8% | 2,474,756 | +2.4% | 0.00% | 0.0% |
| Q2 2023 | $4,350,026 | -8.4% | 2,416,681 | -15.5% | 0.00% | 0.0% |
| Q1 2023 | $4,747,550 | -53.5% | 2,859,970 | -46.2% | 0.00% | -50.0% |
| Q4 2022 | $10,206,587 | -19.3% | 5,315,931 | -5.8% | 0.00% | -33.3% |
| Q3 2022 | $12,642,000 | -30.6% | 5,643,745 | +0.4% | 0.00% | -40.0% |
| Q2 2022 | $18,216,000 | -42.1% | 5,622,235 | -6.1% | 0.01% | -16.7% |
| Q1 2022 | $31,483,000 | -32.7% | 5,985,223 | +8.7% | 0.01% | -40.0% |
| Q4 2021 | $46,786,000 | -16.8% | 5,504,271 | -2.8% | 0.01% | -16.7% |
| Q3 2021 | $56,265,000 | -3.5% | 5,660,489 | -12.1% | 0.01% | -7.7% |
| Q2 2021 | $58,304,000 | -15.3% | 6,440,189 | -2.2% | 0.01% | -23.5% |
| Q1 2021 | $68,831,000 | – | 6,586,674 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 22,957,340 | $120,756,000 | 24.71% |
| Aisling Capital Management LP | 2,541,009 | $13,366,000 | 7.21% |
| EDBI Pte Ltd | 1,270,504 | $6,683,000 | 4.45% |
| Ally Bridge Group (NY) LLC | 1,137,152 | $5,981,000 | 4.43% |
| EcoR1 Capital, LLC | 13,896,543 | $73,096,000 | 2.29% |
| Boxer Capital, LLC | 4,341,009 | $22,834,000 | 1.17% |
| Baupost Group | 10,443,494 | $54,933,000 | 0.59% |
| Redmile Group, LLC | 3,471,709 | $18,261,000 | 0.57% |
| Avidity Partners Management LP | 4,855,006 | $25,537,000 | 0.53% |
| Abrams Capital Management | 3,811,513 | $20,049,000 | 0.47% |